ReviewFrontiers in endocrinology2020

Chemokines as Drivers of the Autoimmune Destruction in Type 1 Diabetes: Opportunity for Therapeutic Intervention in Consideration of an Optimal Treatment Schedule.

Urs Christen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.